Researchers at UBC Okanagan have made two major discoveries that are set to revolutionize how scientists observe and measure molecular forces within living cells. Published recently in two ...

BERLIN & NAPLES, Fla.--(BUSINESS WIRE)--Bayer, a leading company in key areas of radiology and cardiology, and Attralus, Inc. (Attralus), a clinical stage biopharmaceutical company focused on ...

Radiopharmaceutical therapy and molecular imaging—together known as Theranostics—are gaining significant traction worldwide. Even though Theranostics dates back to the early 1940s, a rapid expansion ...

Novel approaches in molecular imaging and targeted therapeutics are transforming the management of renal cell carcinoma (RCC) and urothelial carcinoma (UC). This review focuses on three key areas of ...

Transitioning molecular imaging from a preclinical technique to a standard clinical tool could help detect the very earliest stages of disease, reports Tami Freeman Tools of the trade Left: this ...

A new molecular imaging agent can accurately identify a crucial biomarker found among many different types of cancer. Precise visualization of the trophoblast cell surface antigen 2 (Trop2) biomarker ...

The Case Comprehensive Cancer Center will host its next seminar series event Friday, Feb. 2, from noon to 1 p.m. in the Iris S. and Bert L. Wolstein Research Building auditorium. The event will ...

(RTTNews) - Lantheus Holdings Inc. (LNTH), a radiopharmaceutical-focused company, announced Monday a definitive agreement to acquire Life Molecular Imaging Ltd., a unit of Life Healthcare Group ...

Opportunities in the Middle East imaging biomarkers market include the expansion of advanced imaging infrastructure and increased adoption of biomarker-driven clinical pathways. Driven by rising ...